Fevisafe

Fevisafe 400 Tablet is a medicine that belongs to a class of medicines called antiviral medicines. Fevisafe 400 Tablet is used for managing patients suffering from mild to moderate Covid-19 infection.

Fevisafe 400 Tablet is best taken in mildly infected individuals than in those who have severe Covid-19 infection. This is because early use of antiviral medicines, such as Fevisafe 400 Tablet, is seen to be more effective in treating Covid-19 infection. Delay in treatment only slows down the recovery process and worsens the existing symptoms such as breathing issues, cough, or fever. If left untreated, this viral infection may even lead to organ failure. Once tested positive for Covid-19, consult your doctor immediately.

Fevisafe 400 Tablet should not be used for treating patients who are allergic to Fevisafe 400 Tablet or any of its ingredients. Children should not be given Fevisafe 400 Tablet. It should not be given to patients with severe kidney or liver disease too. Additionally, people who have any abnormal uric acid levels or are suffering from gout must inform their doctor before taking Fevisafe 400 Tablet. If you are planning a baby, pregnant or breastfeeding, consult your doctor before starting treatment with Fevisafe 400 Tablet to avoid any potential harm to your baby. Follow your doctor’s instructions carefully to get maximum benefit.

Fevisafe 400 Tablet should be taken in the dose and duration advised by the doctor. It is taken orally (by mouth) and the recommended dose is 1,800 mg twice on day 1, followed by 800 mg twice daily up to day 14. Do not self medicate. Follow your doctor’s instructions carefully to get maximum benefit from Fevisafe 400 Tablet.

Since the elderly often have compromised organ functions, Fevisafe 400 Tablet should be given with care to them, alongside regular monitoring. Fevisafe 400 Tablet has not been administered in children. However, some early experimental data suggests that Fevisafe 400 Tablet may cause serious side effects in the younger age group. Therefore, this medicine should not be consumed by the elderly and children, unless advised by your doctor.

No, Fevisafe 400 Tablet should not be used for treating Covid-19 infection in pregnant or breastfeeding women. Fevisafe 400 Tablet is not considered safe to be used in pregnant or breastfeeding mothers as its use may cause harmful effects on the baby. If you are planning a baby, pregnant or breastfeeding, consult your doctor if you are tested positive for Covid-19 or even if you are suspected of Covid-19 infection. Your doctor will decide what is best for you depending on your condition.

Fevisafe 400 Tablet inhibits replication (a process by which this virus multiplies) of the Covid-19 virus and stops the further spread of the infection. In this way the amount of virus in the human body decreases, thereby leading to faster recovery.

Fevisafe 400 Tablet should be stored at a temperature not more than 30 degrees Celsius. Make sure to keep it away from the reach of children.

Yes. Fevisafe 400 Tablet may be given to patients with comorbidities such as diabetes and hypertension, under medical supervision. Follow your doctor’s instructions carefully to get the maximum benefit.